BSE filing, NSE: CHEMCRUX. Summary written from the filing by ALFA Finder's alert engine.
Chemcrux Enterprises Ltd: key numbers
- Share price
- ₹82.20
- Market cap
- ₹121.7 Cr
- Revenue (annual)
- ₹80.65 Cr
- Net profit (annual)
- ₹3.73 Cr
- P/E (TTM)
- 29.4×Sector 34.1×
- Promoter holding
- 72.92%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemcrux Enterprises Ltd
All →Chemcrux Enterprises Board Meeting Date
Chemcrux Enterprises intimated a Board Meeting scheduled for 02 November 2026 to approve unaudited financial results for Q2 and H1 FY2026-27. The trading window for insiders remains closed until 48 hours after results are published.
Chemcrux Enterprises Other Announcement
Chemcrux Enterprises Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This disclosure provides details on the company's equity structure and stakeholder ownership.
Chemcrux Enterprises Management Change
Chemcrux Enterprises Ltd regularised the appointment of Ms. Zarna Pankaj Thakar as an Independent Director for one year, effective August 4, 2026, per AGM approval.
Chemcrux Enterprises Annual General Meeting
Chemcrux Enterprises held its 30th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement approval and dividend declaration.
Chemcrux Enterprises Management Change
Mr. Bhanubhai Patel and Mr. Shailesh Patel have ceased to be Independent Directors of the Company following the completion of their second five-year tenure.
Chemcrux Enterprises Dividend
Chemcrux Enterprises Limited recommended a final dividend of Re. 1 per equity share for FY 2025-26. The payment follows the upcoming General Meeting.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.